Immune Status Tied to Outcomes in Third - Gen CAR T - Cell Therapy

In leukemia/lymphoma, after treatment CD19 - targeting chimeric antigen receptor T - cell therapy
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pathology, Conference News, Source Type: news